CATX
Perspective Therapeutics Inc.
NYSE MKT: CATX · HEALTHCARE · MEDICAL DEVICES
$3.90
-0.89% today
Updated 2026-04-30
Market cap
$514.22M
P/E ratio
—
P/S ratio
581.70x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D9.0
Quality
A+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
3.3
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$13.00
+233.76%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.31 — safe zone
+ Debt/equity 0.01x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-20.21M
- Revenue declining -43.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $7.10M | $1.43M | $0.00 | $0.00 | $884000.00 |
| Net income | $-14.67M | $-46.51M | $-79.28M | $-103.12M | $-37.49M |
| EPS | — | — | — | — | $-1.41 |
| Free cash flow | $-12.47M | $-37.98M | $-72.71M | $-95.23M | $-20.21M |
| Profit margin | -206.50% | -3,243.24% | — | — | — |
Peer comparison
Smart narrative
Perspective Therapeutics Inc. trades at $3.90. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 3.31, it sits in the safe zone. TTM revenue stands at $884000.00.
Frequently asked questions
What is Perspective Therapeutics Inc.'s stock price?
Perspective Therapeutics Inc. (CATX) trades at $3.90.
Is Perspective Therapeutics Inc. overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Perspective Therapeutics Inc. (CATX)?
The analyst target price is $13.00, representing +233.8% upside from the current price of $3.90.
What is Perspective Therapeutics Inc.'s revenue?
TTM revenue is $884000.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
3.31 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio581.70x
ROE-41.60%
Beta1.87
50D MA$4.77
200D MA$3.64
Shares out0.11B
Float0.07B
Short ratio—
Avg volume1.6M
Performance
1 week-7.97%
1 month+4.91%
3 months+58.15%
YTD+55.27%
1 year—
3 years—
5 years—